Acute transverse myelitis: Demyelinating, inflammatory, and infectious myelopathies

Seminars in Neurology

Volumn 32, Issue 2, 2012, Pages 97-113

  West, Timothy W ^a   Hess, Christopher ^b   Cree, Bruce A C ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

demyelinating; inflammatory; myelitis; myelopathy

Indexed keywords

AZATHIOPRINE; BIOLOGICAL MARKER; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GLUCOSE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; OLIGOCLONAL BAND; PROTEIN; RITUXIMAB;

ACUTE DSSEMINATED ENCEPHALOMYELITIS; ACUTE TRANSVERSE MYELITIS; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL MENINGITIS; CELL COUNT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ASSESSMENT TOOL; CORTICOSTEROID THERAPY; CYANOCOBALAMIN DEFICIENCY; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ENCEPHALOMYELITIS; HUMAN; IDIOPATHIC DISEASE; IGG INDEX; IMAGE ANALYSIS; LUMBAR PUNCTURE; LYME DISEASE; LYME MYELITIS; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; SJOEGREN SYNDROME; SPINAL CORD DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULOUS MENINGITIS;

ANIMALS; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFLAMMATION; MYELITIS; MYELITIS, TRANSVERSE; SPINAL CORD;

EID: 84865793912     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0032-1322586     Document Type: Article

References (150)

1. Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myelitis: incidence and etiologic considerations. Neurology: 1981; 31 8 966 971
2. Jeffery DR, Mandler RN, Davis LE. Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol: 1993; 50 5 532 535
3. Klein NP, Ray P, Carpenter D., et al. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine: 2010; 28 4 1062 1068
4. Young J, Quinn S, Hurrell M, Taylor B. Clinically isolated acute transverse myelitis: prognostic features and incidence. Mult Scler: 2009; 15 11 1295 1302
5. Bhat A, Naguwa S, Cheema G, Gershwin ME. The epidemiology of transverse myelitis. Autoimmun Rev: 2010; 9 5 A395 A399
6. Alvarenga MP, Thuler LC, Neto SP., et al. The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro. J Neurol: 2010; 257 6 992 998
7. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology: 2002; 59 4 499 505
8. Altrocchi PH. Acute transverse myelopathy. Arch Neurol: 1963; 9 111 119
9. Debette S, de Sèze J, Pruvo JP., et al. Long-term outcome of acute and subacute myelopathies. J Neurol: 2009; 256 6 980 988
10. de Seze J, Lanctin C, Lebrun C., et al. Idiopathic acute transverse myelitis: application of the recent diagnostic criteria. Neurology: 2005; 65 12 1950 1953
11. Jacob A, Weinshenker BG. An approach to the diagnosis of acute transverse myelitis. Semin Neurol: 2008; 28 1 105 120
12. Kumar N. Pearls: myelopathy. Semin Neurol: 2010; 30 1 38 43
13. Pittock SJ, Lucchinetti CF, Parisi JE., et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol: 2005; 58 1 96 107
14. Coleman RJ, Russon L, Blanshard K, Currie S. Useless hand of Oppenheimmagnetic resonance imaging findings. Postgrad Med J: 1993; 69 808 149 150
15. Takeuchi A, Miyamoto K, Hosoe H, Shimizu K. Thoracic paraplegia due to missed thoracic compressive lesions after lumbar spinal decompression surgery. Report of three cases. J Neurosurg: 2004; 100 1, Suppl Spine 71 74
16. Kelley BJ, Erickson BJ, Weinshenker BG. Compressive myelopathy mimicking transverse myelitis. Neurologist: 2010; 16 2 120 122
17. Schmalstieg WF, Weinshenker BG. Approach to acute or subacute myelopathy. Neurology: 2010; 75 18, Suppl 1 S2 S8
18. Sá MJ. Acute transverse myelitis: a practical reappraisal. Autoimmun Rev: 2009; 9 2 128 131
19. Suchett-Kaye AI. Acute transverse myelitis complicating pneumonia; report of a case. Lancet: 1948; 2 6524 417
20. Kerr D. The History of TM: The Origins of the Name and the Identification of the Disease. 2010. Available at: http://www.myelitis.org/history.htm. Accessed July 18, 2012
21. Ghezzi A, Bergamaschi R, Martinelli V., et al. Italian Devic's Study Group (IDESG). Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica. J Neurol: 2004; 251 1 47 52
22. DeSanto J, Ross JS. Spine infection/inflammation. Radiol Clin North Am: 2011; 49 1 105 127
23. Irani DN. Cerebrospinal Fluid in Clinical Practice. Philadelphia, PA Saunders Elsevier: 2009; 317
24. Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Transverse myelitis: pathogenesis, diagnosis and treatment. Front Biosci: 2004; 9 1483 1499
25. Correale J, Fiol M. Activation of humoral immunity and eosinophils in neuromyelitis optica. Neurology: 2004; 63 12 2363 2370
26. Heinlein AC, Gertner E. Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus. Lupus: 2007; 16 10 823 826
27. Compston A. McAlpine's Multiple Sclerosis. 4th ed. Philadelphia, PA Churchill Livingstone Elsevier: 2005
28. Andersson M, Alvarez-Cermeño J, Bernardi G., et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry: 1994; 57 8 897 902
29. Tintoré M, Rovira A, Río J., et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology: 2008; 70 13 Pt 2 1079 1083
30. Tintoré M, Rovira A, Brieva L., et al. Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS. Mult Scler: 2001; 7 6 359 363
31. Lebrun C, Bensa C, Debouverie M., et al. Club Francophone de la Sclérose en Plaques. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Arch Neurol: 2009; 66 7 841 846
32. Collongues N, Marignier R, Zéphir H., et al. Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology: 2010; 74 9 736 742
33. Link H, Huang YM. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol: 2006; 180 1-2 17 28
34. Kaplin AI, Deshpande DM, Scott E., et al. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Invest: 2005; 115 10 2731 2741
35. Graber JJ, Allie SR, Mullen KM., et al. Interleukin-17 in transverse myelitis and multiple sclerosis. J Neuroimmunol: 2008; 196 1-2 124 132
36. Içöz S, Tüzün E, Kürtüncü M., et al. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients. Int J Neurosci: 2010; 120 1 71 75
37. Lennon VA, Wingerchuk DM, Kryzer TJ., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet: 2004; 364 9451 2106 2112
38. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology: 2006; 66 10 1485 1489
39. Collongues N, Marignier R, Zéphir H., et al. High-risk syndrome for neuromyelitis optica: a descriptive and comparative study. Mult Scler: 2011; 17 6 720 724
40. Pittock SJ, Lennon VA, de Seze J., et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol: 2008; 65 1 78 83
41. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol: 2007; 6 9 805 815
42. Franciotta D, Zardini E, Caporali R., et al. Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis. J Neurol Sci: 2011; 303 1-2 139 141
43. Sergio P, Mariana B, Alberto O., et al. Association of neuromyelitis optic (NMO) with autoimmune disorders: report of two cases and review of the literature. Clin Rheumatol: 2010; 29 11 1335 1338
44. Mueller S, Dubal DB, Josephson SA. A case of paraneoplastic myelopathy associated with the neuromyelitis optica antibody. Nat Clin Pract Neurol: 2008; 4 5 284 288
45. Weinshenker BG, Wingerchuk DM, Vukusic S., et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol: 2006; 59 3 566 569
46. Hummers LK, Krishnan C, Casciola-Rosen L., et al. Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology: 2004; 62 1 147 149
47. Fisniku LK, Brex PA, Altmann DR., et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain: 2008; 131 Pt 3 808 817
48. Wingerchuk DM. Diagnosis and treatment of neuromyelitis optica. Neurologist: 2007; 13 1 2 11
49. Al-Araji AH, Oger J. Reappraisal of Lhermitte's sign in multiple sclerosis. Mult Scler: 2005; 11 4 398 402
50. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology: 1999; 53 5 1107 1114
51. Montalban X, Tintoré M, Swanton J., et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology: 2010; 74 5 427 434
52. Miller DH, Filippi M, Fazekas F., et al. Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol: 2004; 56 2 273 278
53. Bizzoco E, Lolli F, Repice AM., et al. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol: 2009; 256 11 1891 1898
54. Takahashi T, Miyazawa I, Misu T., et al. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J Neurol Neurosurg Psychiatry: 2008; 79 9 1075 1078
55. Apiwattanakul M, Popescu BF, Matiello M., et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol: 2010; 68 5 757 761
56. Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica. Neurology: 2005; 65 9 1479 1482
57. Cree BA, Wingerchuk DM. Acute transverse myelitis: is the "idiopathico" form vanishing? Neurology: 2005; 65 12 1857 1858
58. Bruna J, Martínez-Yélamos S, Martínez-Yélamos A, Rubio F, Arbizu T. Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases. Mult Scler: 2006; 12 2 169 173
59. West SG. Neuropsychiatric lupus. Rheum Dis Clin North Am: 1994; 20 1 129 158
60. Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis: 2000; 59 2 120 124
61. D'Cruz DP, Mellor-Pita S, Joven B., et al. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol: 2004; 31 2 280 285
62. Espinosa G, Mendizábal A, Mínguez S., et al. Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients. Semin Arthritis Rheum: 2010; 39 4 246 256
63. Birnbaum J, Petri M, Thompson R, Izbudak I, Kerr D. Distinct subtypes of myelitis in systemic lupus erythematosus. Arthritis Rheum: 2009; 60 11 3378 3387
64. Alexander EL, Malinow K, Lejewski JE, Jerdan MS, Provost TT, Alexander GE. Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med: 1986; 104 3 323 330
65. Alexander GE, Provost TT, Stevens MB, Alexander EL. Sjögren syndrome: central nervous system manifestations. Neurology: 1981; 31 11 1391 1396
66. de Seze J, Devos D, Castelnovo G., et al. The prevalence of Sjögren syndrome in patients with primary progressive multiple sclerosis. Neurology: 2001; 57 8 1359 1363
67. Noseworthy JH, Bass BH, Vandervoort MK., et al. The prevalence of primary Sjögren's syndrome in a multiple sclerosis population. Ann Neurol: 1989; 25 1 95 98
68. Miró J, Peña-Sagredo JL, Berciano J, Insúa S, Leno C, Velarde R. Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis. Ann Neurol: 1990; 27 5 582 584
69. Sandberg-Wollheim M, Axéll T, Hansen BU., et al. Primary Sjögren's syndrome in patients with multiple sclerosis. Neurology: 1992; 42 4 845 847
70. Morgen K, McFarland HF, Pillemer SR. Central nervous system disease in primary Sjogrens syndrome: the role of magnetic resonance imaging. Semin Arthritis Rheum: 2004; 34 3 623 630
71. Delalande S, de Seze J, Fauchais AL., et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore): 2004; 83 5 280 291
72. Gökçay F, Celebisoy N, Gökçay A, Kabasakal Y, Oder G. Primary Sjögrens syndrome presenting as neuromyelitis optica. Pediatr Neurol: 2007; 36 1 58 60
73. Mochizuki A, Hayashi A, Hisahara S, Shoji S. Steroid-responsive Devic's variant in Sjögren's syndrome. Neurology: 2000; 54 6 1391 1392
74. Yamamoto T, Ito S, Hattori T. Neurological picture. Acute longitudinal myelitis as the initial manifestation of Sjögren's syndrome. J Neurol Neurosurg Psychiatry: 2006; 77 6 780
75. Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med: 1977; 87 3 336 345
76. Aksamit A. Neurologic Manifestations of Systemic Disease. Philadelphia, PA Lippincott Williams & Wilkins: 2008; 266
77. Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM: 2009; 102 7 449 460
78. Joseph FG, Scolding NJ. Neurosarcoidosis: a study of 30 new cases. J Neurol Neurosurg Psychiatry: 2009; 80 3 297 304
79. Solomon A, Kreel L, McNicol M, Johnson N. Computed tomography in pulmonary sarcoidosis. J Comput Assist Tomogr: 1979; 3 6 754 758
80. Maña J, Teirstein AS, Mendelson DS, Padilla ML, DePalo LR. Excessive thoracic computed tomographic scanning in sarcoidosis. Thorax: 1995; 50 12 1264 1266
81. Cohen-Aubart F, Galanaud D, Grabli D., et al. Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31 patients in a case-control study. Medicine (Baltimore): 2010; 89 2 133 140
82. Braun JJ, Kessler R, Constantinesco A, Imperiale A. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging: 2008; 35 8 1537 1543
83. Ainslie GM, Benatar SR. Serum angiotensin converting enzyme in sarcoidosis: sensitivity and specificity in diagnosis: correlations with disease activity, duration, extra-thoracic involvement, radiographic type and therapy. Q J Med: 1985; 55 218 253 270
84. Bunting PS, Szalai JP, Katic M. Diagnostic aspects of angiotensin converting enzyme in pulmonary sarcoidosis. Clin Biochem: 1987; 20 3 213 219
85. Terushkin V, Stern BJ, Judson MA., et al. Neurosarcoidosis: presentations and management. Neurologist: 2010; 16 1 2 15
86. Mañá J, Pujol R, Salazar A, Morera J, Fité E, Badrinas F. [The Kveim-Siltzbach test in sarcoidosis]. Med Clin (Barc): 1995; 104 17 645 647
87. Sharma OP. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med: 2000; 6 5 442 447
88. Agmon-Levin N, Kivity S, Szyper-Kravitz M, Shoenfeld Y. Transverse myelitis and vaccines: a multi-analysis. Lupus: 2009; 18 13 1198 1204
89. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology: 2002; 59 8 1224 1231
90. Huynh W, Cordato DJ, Kehdi E, Masters LT, Dedousis C. Post-vaccination encephalomyelitis: literature review and illustrative case. J Clin Neurosci: 2008; 15 12 1315 1322
91. Denholm JT, Neal A, Yan B., et al. Acute encephalomyelitis syndromes associated with H1N1 09 influenza vaccination. Neurology: 2010; 75 24 2246 2248
92. Wildemann B, Jarius S, Hartmann M, Regula JU, Hametner C. Acute disseminated encephalomyelitis following vaccination against human papilloma virus. Neurology: 2009; 72 24 2132 2133
93. Garin CH, Bujadoux CH. Paralysie par les tiques. J Med Lyon: 1922; 71 765 767
94. Bannwarth A. Chronische lymphocytare Meningitis, entzun- dliche Polyneuritis und "Rheumatismuso" Arch Psychiatr Nervenkr: 1941; 113 284 376
95. Bannwarth A. Zur Klinik und Pathogenese der "chronischen lymphocytaren Meningitiso" Arch Psychiatr Nervenkr: 1944; 117 161 185
96. Christen HJ, Hanefeld F. Neurologic complications of ery- thema-migrans-disease in childhood-clinical aspects. Zentralbl Bakteriol Mikrobiol Hyg A: 1986; 263 337 342
97. Bateman DE, Lawton NF, White JE, Greenwood RJ, Wright DJ. The neurological complications of Borrelia burgdorferi in the New Forest area of Hampshire. J Neurol Neurosurg Psychiatry: 1988; 51 5 699 703
98. Kohler J. Lyme borreliosis: a case of transverse myelitis with syrinx cavity. Neurology: 1989; 39 11 1553 1554
99. Rousseau JJ, Lust C, Zangerle PF, Bigaignon G. Acute transverse myelitis as presenting neurological feature of Lyme disease. Lancet: 1986; 2 8517 1222 1223
100. Olivares JP, Pallas F, Ceccaldi M., et al. Lyme disease presenting as isolated acute urinary retention caused by transverse myelitis: an electrophysiological and urodynamical study. Arch Phys Med Rehabil: 1995; 76 12 1171 1172
101. van Baalen A, Muhle H, Straube T, Jansen O, Stephani U. Nonparalytic poliomyelitis in Lyme borreliosis. Arch Dis Child: 2006; 91 8 660
102. Charles V, Duprez TP, Kabamba B, Ivanoiu A, Sindic CJ. Poliomyelitis-like syndrome with matching magnetic resonance features in a case of Lyme neuroborreliosis. BMJ Case Rep: 2009; 2009
103. De Cauwer H, Declerck S, De Smet J., et al. Motor neuron disease features in a patient with neuroborreliosis and a cervical anterior horn lesion. Acta Clin Belg: 2009; 64 3 225 227
104. Koc F, Bozdemir H, Pekoz T., et al. Lyme disease presenting as subacute transverse myelitis. Acta Neurol Belg: 2009; 109 4 326 329
105. Kacinski M, Zajac A, Skowronek-Bala B., et al. CNS Lyme disease manifestation in children. Przegl Lek: 2007; 64 03 38 40
106. Meurs L, Labeye D, Declercq I, Pieret F, Gille M. Acute transverse myelitis as a main manifestation of early stage II neuroborreliosis in two patients. Eur Neurol: 2004; 52 3 186 188
107. Melhem ER, Breiter SN, Ulug AM, Raymond GV, Moser HW. Improved tissue characterization in adrenoleukodystrophy using magnetization transfer imaging. AJR Am J Roentgenol: 1996; 166 3 689 695
108. Smith SA, Golay X, Fatemi A., et al. Magnetization transfer weighted imaging in the upper cervical spinal cord using cerebrospinal fluid as intersubject normalization reference (MTCSF imaging). Magn Reson Med: 2005; 54 1 201 206
109. Brouwer MC, McIntyre P, de Gans J, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev: 2010; 9 CD004405
110. Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev: 2008; 1 CD002244
111. McGee S, Hirschmann J. Use of corticosteroids in treating infectious diseases. Arch Intern Med: 2008; 168 10 1034 1046
112. Kalita J, Misra UK. Is methyl prednisolone useful in acute transverse myelitis? Spinal Cord: 2001; 39 9 471 476
113. Pidcock FS, Krishnan C, Crawford TO., et al. Acute transverse myelitis in childhood: center-based analysis of 47 cases. Neurology: 2007; 68 18 1474 1480
114. Lahat E, Pillar G, Ravid S., et al. Rapid recovery from transverse myelopathy in children treated with methylprednisolone. Pediatr Neurol: 1998; 19 4 279 282
115. Sebire G, Hollenberg H, Meyer L., et al. High dose methylprednisolone in severe acute transverse myelopathy. Arch Dis Child: 1997; 76 2 167 168
116. Defresne P, Meyer L, Tardieu M., et al. Efficacy of high dose steroid therapy in children with severe acute transverse myelitis. J Neurol Neurosurg Psychiatry: 2001; 71 2 272 274
117. Greenberg BM, Thomas KP, Krishnan C., et al. Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide. Neurology: 2007; 68 19 1614 1617
118. Keegan M, Pineda AA, McClelland RL., et al. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology: 2002; 58 1 143 146
119. Bonnan M, Valentino R, Olindo S., et al. Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder. Mult Scler: 2009; 15 4 487 492
120. Ravaglia S, Piccolo G, Ceroni M., et al. Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg. J Neurol: 2007; 254 11 1518 1523
121. Cree BA, Lamb S, Morgan K., et al. An open label study of the effects of rituximab in neuromyelitis optica. Neurology: 2005; 64 7 1270 1272
122. Jacob A, Weinshenker BG, Violich I., et al. Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol: 2008; 65 11 1443 1448
123. Bichuetti DB, Lobato de Oliveira EM, Oliveira DM, Amorin de Souza N, Gabbai AA. Neuromyelitis optica treatment: analysis of 36 patients. Arch Neurol: 2010; 67 9 1131 1136
124. Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L., et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis: 2005; 64 4 620 625
125. Berger J. CONTINUUM: Lifelong Learning in Neurology - Spinal Cord Disorders. 2005
126. Tracy JA, Bartleson JD. Cervical spondylotic myelopathy. Neurologist: 2010; 16 3 176 187
127. Wiebe S, Lee DH, Karlik SJ., et al. Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis. Ann Neurol: 1992; 32 5 643 650
128. Tenembaum S, Chitnis T, Ness J, Hahn JS. Acute disseminated encephalomyelitis. Neurology: 2007; 68 16 Suppl 2 S23 36
129. Hirai T, Korogi Y, Hamatake S., et al. Case report: varicella-zoster virus myelitis-serial MR findings. Br J Radiol: 1996; 69 828 1187 1190
130. Maschke M, Kastrup O, Diener HC. CNS manifestations of cytomegalovirus infections: diagnosis and treatment. CNS Drugs: 2002; 16 5 303 315
131. Nakajima H, Furutama D, Kimura F., et al. Herpes simplex virus myelitis: clinical manifestations and diagnosis by the polymerase chain reaction method. Eur Neurol: 1998; 39 3 163 167
132. Ferraz-Filho JR, dos Santos Torres U, de Oliveira EP, Souza AS. MRI findings in an infant with vaccine-associated paralytic poliomyelitis. Pediatr Radiol: 2010; 40 01 S138 140
133. Kornreich L, Dagan O, Grunebaum M. MRI in acute poliomyelitis. Neuroradiology: 1996; 38 4 371 372
134. Kramer LD, Li J, Shi PY. West Nile virus. Lancet Neurol: 2007; 6 2 171 181
135. Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol: 2010; 9 11 1097 1105
136. Pittock SJ, Lucchinetti CF. Inflammatory transverse myelitis: evolving concepts. Curr Opin Neurol: 2006; 19 4 362 368
137. Mygland A, Trydal T, Vinje BU, Vedeler C. Isoelectric focusing is superior to immunofixation electrophoresis in diagnosing CNS inflammation. Acta Neurol Scand: 2007; 115 2 122 125
138. Freedman MS, Thompson EJ, Deisenhammer F., et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol: 2005; 62 6 865 870
139. Sadaba MC, Gonzalez Porque P, Masjuan J., et al. An ultrasensitive method for the detection of oligoclonal IgG bands. J Immunol Methods: 2004; 284 1-2 141 145
140. McMillan SA, Douglas JP, Droogan AG, Hawkins SA. Evaluation of formulae for CSF IgG synthesis using data obtained from two methods: importance of receiver operator characteristic curve analysis. J Clin Pathol: 1996; 49 1 24 28
141. Castro R, Prieto ES, da Luz Martins Pereira F. Nontreponemal tests in the diagnosis of neurosyphilis: an evaluation of the Venereal Disease Research Laboratory (VDRL) and the Rapid Plasma Reagin (RPR) tests. J Clin Lab Anal: 2008; 22 4 257 261
142. Cinque P, Bossolasco S, Lundkvist A. Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system. J Clin Virol: 2003; 26 1 1 28
143. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis: 1995; 171 4 857 863
144. Corral I, Quereda C, Antela A., et al. Neurological complications of varicella-zoster virus in human immunodeficiency virus-infected patients: changes in prevalence and diagnostic utility of polymerase chain reaction in cerebrospinal fluid. J Neurovirol: 2003; 9 1 129 135
145. Khoury J, Wellik KE, Demaerschalk BM, Wingerchuk DM. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist: 2009; 15 2 108 111
146. Solomon DH, Kavanaugh AJ, Schur PH. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum: 2002; 47 4 434 444
147. Servais G, Guillaume MP, Dumarey N, Duchateau J. Evidence of autoantibodies to cell membrane associated DNA (cultured lymphocytes): a new specific marker for rapid identification of systemic lupus erythematosus. Ann Rheum Dis: 1998; 57 10 606 613
148. Defendenti C, Atzeni F, Spina MF., et al. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies. Autoimmun Rev: 2011; 10 3 150 154
149. Sanchez-Guerrero J, Lew RA, Fossel AH, Schur PH. Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. Arthritis Rheum: 1996; 39 6 1055 1061
150. Basu D, Reveille JD. Anti-scl-70. Autoimmunity: 2005; 38 1 65 72